NO341594B1 - Biomedisinsk kit for fremstilling av en biokompatibel alginatgel, sammensetning for fremstilling av slike geler, fremgangsmåte for utlevering av en selv-gelerings alginat dispersjon og en implanterbar anordning samt alginatgeler og implanterbare anordninger omfattende slike - Google Patents
Biomedisinsk kit for fremstilling av en biokompatibel alginatgel, sammensetning for fremstilling av slike geler, fremgangsmåte for utlevering av en selv-gelerings alginat dispersjon og en implanterbar anordning samt alginatgeler og implanterbare anordninger omfattende slikeInfo
- Publication number
- NO341594B1 NO341594B1 NO20072013A NO20072013A NO341594B1 NO 341594 B1 NO341594 B1 NO 341594B1 NO 20072013 A NO20072013 A NO 20072013A NO 20072013 A NO20072013 A NO 20072013A NO 341594 B1 NO341594 B1 NO 341594B1
- Authority
- NO
- Norway
- Prior art keywords
- alginate
- dispersion
- preparing
- gels
- dispensing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/256—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seaweeds, e.g. alginates, agar or carrageenan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/729—Agar; Agarose; Agaropectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/734—Alginic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3817—Cartilage-forming cells, e.g. pre-chondrocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3895—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/085—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Developmental Biology & Embryology (AREA)
- Dispersion Chemistry (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Polymers & Plastics (AREA)
- Urology & Nephrology (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Physical Education & Sports Medicine (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61785204P | 2004-10-12 | 2004-10-12 | |
PCT/US2005/036460 WO2006044342A2 (en) | 2004-10-12 | 2005-10-12 | Self-gelling alginate systems and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20072013L NO20072013L (no) | 2007-07-06 |
NO341594B1 true NO341594B1 (no) | 2017-12-11 |
Family
ID=36203445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20072013A NO341594B1 (no) | 2004-10-12 | 2007-04-19 | Biomedisinsk kit for fremstilling av en biokompatibel alginatgel, sammensetning for fremstilling av slike geler, fremgangsmåte for utlevering av en selv-gelerings alginat dispersjon og en implanterbar anordning samt alginatgeler og implanterbare anordninger omfattende slike |
Country Status (12)
Country | Link |
---|---|
US (4) | US7790699B2 (ru) |
EP (1) | EP1799232B1 (ru) |
JP (1) | JP5367266B2 (ru) |
CN (1) | CN101227913B (ru) |
AU (1) | AU2005295927B2 (ru) |
BR (2) | BRPI0515973B8 (ru) |
CA (1) | CA2583373C (ru) |
IL (1) | IL182426A0 (ru) |
MX (1) | MX2007004261A (ru) |
NO (1) | NO341594B1 (ru) |
RU (1) | RU2393867C2 (ru) |
WO (1) | WO2006044342A2 (ru) |
Families Citing this family (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006042132A2 (en) * | 2004-10-08 | 2006-04-20 | Georgia Tech Research Corporation | Microencapsulation of cells in hydrogels using electrostatic potentials |
MX2007004261A (es) | 2004-10-12 | 2007-06-18 | Fmc Biopolymer As | Sistemas de alginato auto-gelificantes y usos de los mismos. |
DK2347775T3 (da) | 2005-12-13 | 2020-07-13 | Harvard College | Skabeloner til celletransplantation |
WO2008018892A2 (en) * | 2005-12-22 | 2008-02-14 | Pluromed, Inc. | Methods and kits for treating lacerations and puncture wounds using inverse thermosensitive polymers |
CA2643083A1 (en) * | 2006-03-01 | 2007-09-13 | Fmc Biopolymer As | Biodegradable foam |
ITPD20060203A1 (it) * | 2006-05-22 | 2007-11-23 | Univ Degli Studi Trieste | Idrogeli di miscele di polisaccaridi per l'ingegneria tissutale e la veicolazione di composti attivi |
ATE552867T1 (de) * | 2006-06-16 | 2012-04-15 | Fmc Biopolymer As | Alginatbeschichtete collagenmatrix- zellvorrichtung, herstellungsverfahren dafür und verwendungen davon |
US20090123596A1 (en) * | 2006-06-21 | 2009-05-14 | Fmc Biopolymer As | Gastro-Activated Dietary Fibers |
WO2008006658A1 (en) * | 2006-07-14 | 2008-01-17 | Fmc Biopolymer As | Hydrogels containing low molecular weight alginates and biostructures made therefrom |
US9782258B2 (en) * | 2006-09-08 | 2017-10-10 | The Regents Of The University Of California | Intramyocardial patterning for global cardiac resizing and reshaping |
WO2008127290A2 (en) * | 2006-10-12 | 2008-10-23 | The Johns Hopkins University | Alginate and alginate lyase compositions and methods of use |
WO2008102340A2 (en) * | 2007-02-20 | 2008-08-28 | Svip 1 Llc | Kits and methods for determining colon cleanliness |
WO2008102341A2 (en) * | 2007-02-20 | 2008-08-28 | Svip 3 Llc | Fecal incontinence device, kit and method |
AU2013204006B2 (en) * | 2007-02-21 | 2015-09-17 | Mochida Pharmaceutical Co., Ltd | Composition for treatment of cartilage disease |
BRPI0807739B1 (pt) * | 2007-02-21 | 2018-06-26 | Mochida Pharmaceutical Co., Ltd. | Composição para o tratamento de doenças da cartilagem |
CN101778891B (zh) * | 2007-06-13 | 2013-01-16 | Fmc有限公司 | 涂覆藻酸盐的含多糖凝胶泡沫复合物,其制备方法及其应用 |
WO2008157280A1 (en) | 2007-06-13 | 2008-12-24 | Fmc Corporation | Implantable degradable biopolymer fiber devices |
WO2009002401A2 (en) | 2007-06-21 | 2008-12-31 | President And Fellows Of Harvard College | Scaffolds for cell collection or elimination |
CN101918007B (zh) * | 2007-08-28 | 2014-06-04 | Fmc有限公司 | 延迟的自胶凝藻酸盐体系及其应用 |
EP2036533A1 (en) * | 2007-09-14 | 2009-03-18 | 3M Innovative Properties Company | Curable Dental Retraction Composition, Method of Production and Use thereof |
BRPI0818719B1 (pt) * | 2007-10-24 | 2018-09-04 | Mochida Pharm Co Ltd | composição para o tratamento de doença articular |
DK2268142T3 (en) | 2007-11-27 | 2017-05-22 | Algipharma As | USING ALGINATED OLIGOMERS TO FIGHT BIOFILM |
EP2082755A1 (de) | 2008-01-16 | 2009-07-29 | CellMed AG | Monolithische in-situ vernetzte Alginatimplantate |
CN102006891B (zh) | 2008-02-13 | 2017-04-26 | 哈佛学院董事会 | 连续的细胞程序化装置 |
US9370558B2 (en) | 2008-02-13 | 2016-06-21 | President And Fellows Of Harvard College | Controlled delivery of TLR agonists in structural polymeric devices |
WO2009146456A1 (en) | 2008-05-30 | 2009-12-03 | President And Fellows Of Harvard College | Controlled release of growth factors and signaling molecules for promoting angiogenesis |
US8367637B2 (en) | 2008-08-19 | 2013-02-05 | Mochida Pharmaceutical Co., Ltd. | Composition for treating arthritic disorder |
FR2937857B1 (fr) * | 2008-10-30 | 2015-04-03 | Brothier Lab | Membrane chirurgicale antiadherence |
WO2010109588A1 (ja) * | 2009-03-23 | 2010-09-30 | 財団法人函館地域産業振興財団 | 医療用及び基礎化粧用(スキンケア用)高分子材料並びにその製造方法 |
WO2010117266A1 (en) | 2009-04-06 | 2010-10-14 | Broockeville Corporation N.V. | In situ gelling alginate systems |
WO2010120749A2 (en) | 2009-04-13 | 2010-10-21 | President And Fellow Of Harvard College | Harnessing cell dynamics to engineer materials |
CN102458474B (zh) | 2009-06-03 | 2014-06-11 | 阿尔吉法玛公司 | 使用藻酸盐低聚物和抗生素治疗不动杆菌 |
US8728456B2 (en) | 2009-07-31 | 2014-05-20 | President And Fellows Of Harvard College | Programming of cells for tolerogenic therapies |
DE102010009475B4 (de) * | 2010-02-26 | 2011-11-24 | F. Holzer Gmbh | Verfahren zur Herstellung eines dosierbaren applikationsfertigen Präparates |
US9610328B2 (en) | 2010-03-05 | 2017-04-04 | President And Fellows Of Harvard College | Enhancement of skeletal muscle stem cell engraftment by dual delivery of VEGF and IGF-1 |
ES2531669T3 (es) | 2010-03-11 | 2015-03-18 | Bender Analytical Holding B.V. | Composición acuosa estéril basada en alginato para uso médico y procedimiento para la preparación de la misma |
CA2794328C (en) | 2010-03-29 | 2018-01-16 | Evonik Degussa Corporation | Compositions and methods for improved retention of a pharmaceutical composition at a local administration site |
EP2585053A4 (en) | 2010-06-25 | 2014-02-26 | Harvard College | COMMON RELEASE OF STIMULATING AND HEMMING FACTORS FOR THE PRODUCTION OF TEMPORARY STABILIZED AND SPATULARLY LIMITED ZONES |
EP2624873B1 (en) | 2010-10-06 | 2019-12-04 | President and Fellows of Harvard College | Injectable, pore-forming hydrogels for materials-based cell therapies |
WO2012064697A2 (en) | 2010-11-08 | 2012-05-18 | President And Fellows Of Harvard College | Materials presenting notch signaling molecules to control cell behavior |
WO2012085609A1 (en) | 2010-12-20 | 2012-06-28 | Dept. Of Pathobiology | Treatment of osteoarthritis by continuous intra-articular injection of alginate gel |
US10647959B2 (en) | 2011-04-27 | 2020-05-12 | President And Fellows Of Harvard College | Cell-friendly inverse opal hydrogels for cell encapsulation, drug and protein delivery, and functional nanoparticle encapsulation |
EP3417876B1 (en) | 2011-04-28 | 2021-03-31 | President and Fellows of Harvard College | Injectable preformed macroscopic 3-dimensional scaffolds for minimally invasive administration |
US9675561B2 (en) | 2011-04-28 | 2017-06-13 | President And Fellows Of Harvard College | Injectable cryogel vaccine devices and methods of use thereof |
US8404256B2 (en) * | 2011-05-06 | 2013-03-26 | The University Of Memphis Research Foundation | Biomaterial composite composition and method of use |
US9486512B2 (en) | 2011-06-03 | 2016-11-08 | President And Fellows Of Harvard College | In situ antigen-generating cancer vaccine |
WO2013039380A1 (en) | 2011-09-15 | 2013-03-21 | Bender Analytical Holding B.V. | Sterile alginate-based aqueous composition for medical use and process for the preparation thereof |
GB201120368D0 (en) | 2011-11-24 | 2012-01-04 | Sperm Vital As | Methods for the preparation of hydrogels |
US8877259B2 (en) | 2012-02-09 | 2014-11-04 | Mary Kay Inc. | Cosmetic formulation |
LT2838515T (lt) | 2012-04-16 | 2020-03-10 | President And Fellows Of Harvard College | Mezoporinės silico dioksido kompozicijos, skirtos imuninio atsako moduliavimui |
US20160287744A1 (en) * | 2012-11-14 | 2016-10-06 | 3-D Matrix Ltd. | Vascular embolic system |
CN102993330B (zh) * | 2012-12-20 | 2014-12-24 | 青岛明月海藻集团有限公司 | 一种齿科印模材料用藻酸盐的制备方法 |
US20150368616A1 (en) * | 2013-02-14 | 2015-12-24 | The Cleveland Clinic Foundation | Methods for induction of cell fates from pluripotent cells |
MD669Z (ru) * | 2013-03-14 | 2014-03-31 | Ольга ДИМОВА | Способ получения альгинатов из бурых водорослей |
RU2535035C1 (ru) * | 2013-09-11 | 2014-12-10 | Общество с ограниченной ответственностью "КОЛЕТЕКС" | Способ получения стерильной саможелирующейся альгинатной системы |
WO2015097236A2 (en) | 2013-12-24 | 2015-07-02 | Ares Trading S.A | Fgf-18 formulation in alginate/collagen hydrogels |
CN107073090A (zh) | 2014-04-30 | 2017-08-18 | 哈佛学院董事会 | 结合的疫苗装置和杀死癌细胞的方法 |
WO2015175457A1 (en) * | 2014-05-12 | 2015-11-19 | Jonathan Allen Rowley | Ready-to-print cells and integrated devices |
CN107073176B (zh) * | 2014-06-09 | 2021-02-19 | 康奈尔大学 | 可植入治疗递送系统及其方法 |
US9295752B1 (en) | 2014-09-30 | 2016-03-29 | Covidien Lp | Bioadhesive for occluding vessels |
WO2016114355A1 (ja) * | 2015-01-15 | 2016-07-21 | 国立大学法人東京大学 | 癒着防止用組成物 |
CA3012602A1 (en) | 2015-01-30 | 2016-08-04 | President And Fellows Of Harvard College | Peritumoral and intratumoral materials for cancer therapy |
US20160243244A1 (en) * | 2015-02-24 | 2016-08-25 | EmboMedics, Inc. | Method and system for alleviating joint pain |
WO2016164705A1 (en) | 2015-04-10 | 2016-10-13 | Omar Abdel-Rahman Ali | Immune cell trapping devices and methods for making and using the same |
WO2017004071A1 (en) * | 2015-06-29 | 2017-01-05 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Stapled acid-sensitive endosome disrupting alginates |
US9655842B1 (en) | 2015-12-04 | 2017-05-23 | Covidien Lp | Injectable non-aqueous compositions and methods of treating vascular disease |
CN105504087B (zh) * | 2016-01-28 | 2017-11-14 | 杭州德柯医疗科技有限公司 | 医用级海藻酸钙的制备方法 |
CN109072197A (zh) | 2016-02-06 | 2018-12-21 | 哈佛学院校长同事会 | 重塑造血巢以重建免疫 |
WO2017139487A1 (en) | 2016-02-09 | 2017-08-17 | Northwind Medical, Inc. | Methods, agents, and devices for local neuromodulation of autonomic nerves |
RU2618435C1 (ru) * | 2016-04-15 | 2017-05-03 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В.Ломоносова" (МГУ) | Способ микроинкапсулирования стволовых клеток |
CN109789092A (zh) | 2016-07-13 | 2019-05-21 | 哈佛学院院长等 | 抗原呈递细胞模拟支架及其制备和使用方法 |
WO2019025982A1 (en) * | 2017-08-03 | 2019-02-07 | Ortho-Space Ltd. | SELF-HEALING BALLOON |
US11872328B2 (en) | 2017-08-30 | 2024-01-16 | Hadasit Medical Research Services And Development Ltd. | Devices, kits and methods for reducing and/or preventing intra-abdominal adhesions |
US20200214484A1 (en) * | 2017-08-31 | 2020-07-09 | Loliware Inc. | Sugar-free edible vessel |
WO2019047954A1 (en) * | 2017-09-08 | 2019-03-14 | L'oreal | SKIN CARE KIT |
EP3501553A1 (en) * | 2017-12-21 | 2019-06-26 | Association for the Advancement of Tissue Engineering and Cell based Technologies & Therapies (A4TEC) - Associação | Hydrogel comprising manganese, methods and uses thereof |
GB201801014D0 (en) * | 2018-01-22 | 2018-03-07 | Univ Newcastle | Storage and/or transport for multicellular aggregates |
JP7492917B2 (ja) | 2018-02-09 | 2024-05-30 | デシベル セラピューティクス インコーポレイテッド | 抗白金化学保護剤を含む高張医薬組成物 |
US11103618B2 (en) * | 2018-02-22 | 2021-08-31 | Warsaw Orthopedic, Inc. | Demineralized bone matrix having improved handling characteristics |
JP7366919B2 (ja) * | 2018-03-27 | 2023-10-23 | ラミナリア、グループ、アクチボラグ | 栄養補助食品 |
EP3817786A4 (en) | 2018-07-02 | 2022-03-23 | Tulavi Therapeutics, Inc. | METHODS AND DEVICES FOR IN SITU FORMED NERVE CAP |
US20210315587A1 (en) * | 2018-07-02 | 2021-10-14 | Tulavi Therapeutics, Inc. | Methods and devices for in situ formed nerve cap with rapid release |
US20210369875A1 (en) * | 2018-11-06 | 2021-12-02 | National Cancer Center | Alginic acid-based injectable hydrogel system |
CN109735496A (zh) * | 2019-02-22 | 2019-05-10 | 深圳市罗湖区人民医院 | 一种肿瘤细胞化疗药物三维耐药模型及其建立方法 |
CN113498336A (zh) * | 2019-03-08 | 2021-10-12 | 莱雅公司 | 用于皮肤护理的试剂盒 |
CN109894095B (zh) * | 2019-03-28 | 2022-10-14 | 北京工业大学 | 一种含铁锰氧化物的海藻酸钠-壳聚糖复合凝胶微球吸附除砷材料及其制备方法 |
US10813947B1 (en) | 2019-05-31 | 2020-10-27 | Decibel Therapeutics, Inc. | Methods of otoprotection against platinum-based antineoplastic agents |
US20220349896A1 (en) * | 2019-09-27 | 2022-11-03 | Sigilon Therapeutics, Inc. | Methods of evaluating polypeptide-modified polymers in compositions |
CN111235921A (zh) * | 2020-01-21 | 2020-06-05 | 湖北工业大学 | 有效提高粘度与增稠特性的海藻酸钠溶液及其制备方法与应用 |
WO2021217560A1 (en) * | 2020-04-30 | 2021-11-04 | L'oreal | Kit for caring for the skin |
CA3190689A1 (en) | 2020-08-31 | 2022-03-03 | The Board Of Trustees Of University Of Illinois | Alginate-coated mesenchymal stromal and progenitor cells and methods for using the same |
CN114430042B (zh) * | 2020-10-13 | 2023-09-29 | 中国石油化工股份有限公司 | 一种用于锂电池添加剂的海藻酸锂及其制备方法和应用 |
EP4358740A1 (en) | 2021-06-23 | 2024-05-01 | Loliware Inc. | Bio-based, biodegradable compositions and articles made therefrom |
NO347755B1 (en) | 2021-10-21 | 2024-03-18 | Blue Wave Therapeutics Gmbh | Peptide-coupled alginate gels comprising radionuclides |
CN115260544B (zh) * | 2022-07-26 | 2024-04-26 | 武汉纺织大学 | 多重交联的3d凝胶材料的快速成型方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB666961A (en) * | 1942-07-27 | 1952-02-20 | Kelco Co | Improvements in gel-forming compositions and methods of forming the same |
US6309380B1 (en) * | 1999-01-27 | 2001-10-30 | Marian L. Larson | Drug delivery via conformal film |
Family Cites Families (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1814981A (en) | 1927-08-06 | 1931-07-14 | Kelco Co | Process of preparing alginic acid and compounds thereof |
GB399822A (en) | 1932-03-12 | 1933-10-12 | British Celanese | Improvements in processes and apparatus for the manufacture of artificial filaments and like materials |
US2420308A (en) | 1942-07-27 | 1947-05-13 | Kelco Co | Gel-forming algin composition and method |
GB1399822A (en) * | 1971-07-30 | 1975-07-02 | Finch E G | Growing medium for application to root-forming plant material |
NO153084C (no) * | 1979-08-01 | 1986-01-15 | Quaker Oats Ltd | Fremgangsmaate for fremstilling av imiterte naeringsmiddelprodukter. |
US4792525A (en) * | 1982-08-04 | 1988-12-20 | La Jolla Cancer Research Foundation | Tetrapeptide |
US4988621A (en) * | 1985-05-24 | 1991-01-29 | La Jolla Cancer Research Foundation | Peptides in cell detachment and aggregation |
US4879237A (en) * | 1985-05-24 | 1989-11-07 | La Jolla Cancer Research Foundation | Use of peptides in control of cell attachment and detachment |
US4789734A (en) * | 1985-08-06 | 1988-12-06 | La Jolla Cancer Research Foundation | Vitronectin specific cell receptor derived from mammalian mesenchymal tissue |
GB8813773D0 (en) | 1988-06-10 | 1988-07-13 | Kelco Int Ltd | Alginate gels |
US5175093A (en) * | 1989-11-07 | 1992-12-29 | Lehigh University | Bioactive cells immobilized in alginate beads containing voids formed with polyethylene glycol |
US5318780A (en) * | 1991-10-30 | 1994-06-07 | Mediventures Inc. | Medical uses of in situ formed gels |
JP3534780B2 (ja) | 1992-01-31 | 2004-06-07 | テルモ株式会社 | 血管塞栓剤 |
US5266326A (en) * | 1992-06-30 | 1993-11-30 | Pfizer Hospital Products Group, Inc. | In situ modification of alginate |
WO1994010976A1 (en) | 1992-11-16 | 1994-05-26 | Ciba Vision Ag, Hettlingen | Polyvinyl alcohol/borate ophthalmic drug delivery system |
US5709854A (en) | 1993-04-30 | 1998-01-20 | Massachusetts Institute Of Technology | Tissue formation by injecting a cell-polymeric solution that gels in vivo |
US5531716A (en) * | 1993-09-29 | 1996-07-02 | Hercules Incorporated | Medical devices subject to triggered disintegration |
US6090763A (en) * | 1994-02-28 | 2000-07-18 | Stewart; Howard Franklin | Hydrogel soap |
GB9414304D0 (en) * | 1994-07-15 | 1994-09-07 | C V Lab Ltd | Fibres, manufacture and use |
US6129761A (en) | 1995-06-07 | 2000-10-10 | Reprogenesis, Inc. | Injectable hydrogel compositions |
US6150581A (en) | 1995-06-07 | 2000-11-21 | United States Surgical Corporation | Chitosan/alginate anti-adhesion barrier |
EP0848621B1 (en) | 1995-07-19 | 2003-03-26 | Advanced Medical Solutions Limited | Wound treatment composition |
JP3984664B2 (ja) * | 1995-12-22 | 2007-10-03 | 日清紡績株式会社 | 創傷被覆材 |
JPH09227412A (ja) * | 1996-02-28 | 1997-09-02 | Dai Ichi High Frequency Co Ltd | 高分子ゲルの製造方法 |
US6090938A (en) | 1996-05-01 | 2000-07-18 | Collaborative Group, Ltd. | Activation of signal transduction by underivatized, aqueous soluble . .beta(1-3)-Glucan |
GB9609474D0 (en) * | 1996-05-08 | 1996-07-10 | Innovative Tech Ltd | Hydrogels |
IL118376A0 (en) * | 1996-05-22 | 1996-09-12 | Univ Ben Gurion | Polysaccharide sponges for cell culture and transplantation |
NO305441B1 (no) | 1996-07-12 | 1999-05-31 | Norsk Hydro As | Anvendelse av G-blokk polysakkarider |
JP4335316B2 (ja) | 1996-09-19 | 2009-09-30 | ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミシガン | アルギネートまたは修飾アルギネートのようなポリサッカライドを含むポリマー |
GB2320502B (en) * | 1996-12-20 | 2000-09-20 | Johnson & Johnson Medical | Bioresorbable alginate derivatives |
US6656508B2 (en) * | 1997-04-17 | 2003-12-02 | Amgen Inc. | Sustained-release alginate gels |
NO305033B1 (no) | 1997-05-09 | 1999-03-22 | Algipharma As | Fremgangsmate for fremstilling av uronsyreblokker fra alginat |
US5965997A (en) * | 1997-08-20 | 1999-10-12 | Benchmarq Microelectronics | Battery monitoring circuit with storage of charge and discharge accumulation values accessible therefrom |
WO1999011191A1 (en) * | 1997-08-28 | 1999-03-11 | Boston Scientific Corporation | System for implanting a cross-linked polysaccharide fiber and methods of forming and inserting the fiber |
US6146655A (en) * | 1997-08-29 | 2000-11-14 | Softy-Flex Inc. | Flexible intra-oral bandage and drug delivery system |
JP2001517494A (ja) | 1997-09-19 | 2001-10-09 | リプロジェネシス・インコーポレーテッド | 組織エンジニアリングのための改良されたヒドロゲル |
DE19881709B4 (de) * | 1997-11-07 | 2008-05-29 | Siemens Ag | Verfahren zum Schneiden eines Metallbandes, das aus einer Warmwalzstraße ausläuft, und Vorrichtung zur Durchführung des Verfahrens |
US6911212B2 (en) * | 1998-02-27 | 2005-06-28 | Musculoskeletal Transplant Foundation | Malleable putty and flowable paste with allograft bone having residual calcium for filling bone defects |
US6432449B1 (en) | 1998-05-18 | 2002-08-13 | Amgen Inc. | Biodegradable sustained-release alginate gels |
DE19836960A1 (de) | 1998-08-14 | 2000-02-17 | Ulrich Zimmermann | Verfahren zur Gewinnung hochgereinigter Alginate |
JP2002530440A (ja) * | 1998-11-13 | 2002-09-17 | シーピー ケルコ ユー.エス.インク. | エンドトキシンレベルが低い生体高分子塩、その生体高分子組成物およびこれを製造する方法 |
US6495161B1 (en) * | 1999-03-09 | 2002-12-17 | Vivorx, Inc. | Cytoprotective biocompatible containment systems for biologically active materials and methods of making same |
JP2000288018A (ja) * | 1999-04-02 | 2000-10-17 | Alcare Co Ltd | 肛門部用ドレッシング |
KR20010010151A (ko) | 1999-07-16 | 2001-02-05 | 김윤 | 수용성 알긴산염과 카르복시메틸 셀룰로오스를 주성분으로 하는 유착방지제 및 그의 제조방법 |
US6497902B1 (en) * | 1999-12-01 | 2002-12-24 | The Regents Of The University Of Michigan | Ionically crosslinked hydrogels with adjustable gelation time |
ES2272482T3 (es) * | 2000-01-20 | 2007-05-01 | Diabcell Pty Limited | Preparacion y xenotransplante de islotes porcinos. |
US6592566B2 (en) * | 2000-02-03 | 2003-07-15 | Arizona Board Of Regents | Method for forming an endovascular occlusion |
US6638917B1 (en) * | 2000-02-25 | 2003-10-28 | Scimed Life Systems, Inc. | Reducing adhesion |
SE0103827D0 (sv) | 2001-11-16 | 2001-11-16 | Mikael Wiberg | Nerve repair unit and method of producing it |
CA2483660A1 (en) | 2002-05-01 | 2003-11-13 | Verigen Ag | Injectable chondrocyte implant |
NO20023581D0 (no) | 2002-07-26 | 2002-07-26 | Fmc Biopolymer As | Nye mutantstammer av Pseudomonas fluorescens og varianter derav, metoder for produksjon og bruk derav til produksjon avalginat |
SI21300A (sl) | 2002-10-08 | 2004-04-30 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Farmacevtske formulacije z alginati |
US7674837B2 (en) * | 2003-09-08 | 2010-03-09 | Fmc Biopolymer As | Gelled biopolymer based foam |
EP2228035A1 (en) * | 2003-12-23 | 2010-09-15 | FMC Biopolymer AS | Use of alginate matrices to control cell growth |
MX2007004261A (es) * | 2004-10-12 | 2007-06-18 | Fmc Biopolymer As | Sistemas de alginato auto-gelificantes y usos de los mismos. |
JO2630B1 (en) | 2006-04-13 | 2012-06-17 | نوفارتيس ايه جي | Organic compounds |
-
2005
- 2005-10-12 MX MX2007004261A patent/MX2007004261A/es active IP Right Grant
- 2005-10-12 CA CA2583373A patent/CA2583373C/en active Active
- 2005-10-12 EP EP05803188.1A patent/EP1799232B1/en active Active
- 2005-10-12 JP JP2007535898A patent/JP5367266B2/ja active Active
- 2005-10-12 BR BRPI0515973A patent/BRPI0515973B8/pt active IP Right Grant
- 2005-10-12 AU AU2005295927A patent/AU2005295927B2/en not_active Ceased
- 2005-10-12 RU RU2007117702/15A patent/RU2393867C2/ru not_active IP Right Cessation
- 2005-10-12 CN CN2005800415278A patent/CN101227913B/zh not_active Expired - Fee Related
- 2005-10-12 US US11/248,984 patent/US7790699B2/en active Active
- 2005-10-12 WO PCT/US2005/036460 patent/WO2006044342A2/en active Application Filing
- 2005-10-12 BR BR122018068450A patent/BR122018068450B8/pt active IP Right Grant
-
2007
- 2007-04-10 IL IL182426A patent/IL182426A0/en active IP Right Grant
- 2007-04-19 NO NO20072013A patent/NO341594B1/no unknown
-
2010
- 2010-08-13 US US12/855,964 patent/US8481695B2/en active Active
-
2013
- 2013-06-28 US US13/930,426 patent/US8741872B2/en active Active
-
2014
- 2014-05-28 US US14/288,767 patent/US9463162B2/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB666961A (en) * | 1942-07-27 | 1952-02-20 | Kelco Co | Improvements in gel-forming compositions and methods of forming the same |
US6309380B1 (en) * | 1999-01-27 | 2001-10-30 | Marian L. Larson | Drug delivery via conformal film |
Also Published As
Publication number | Publication date |
---|---|
EP1799232B1 (en) | 2015-10-07 |
CN101227913A (zh) | 2008-07-23 |
JP2008515927A (ja) | 2008-05-15 |
RU2007117702A (ru) | 2008-11-20 |
US20130288998A1 (en) | 2013-10-31 |
WO2006044342A3 (en) | 2007-12-06 |
BR122018068450B1 (pt) | 2020-12-01 |
CA2583373C (en) | 2013-09-03 |
BRPI0515973A (pt) | 2008-08-12 |
EP1799232A2 (en) | 2007-06-27 |
US8481695B2 (en) | 2013-07-09 |
NO20072013L (no) | 2007-07-06 |
US8741872B2 (en) | 2014-06-03 |
US9463162B2 (en) | 2016-10-11 |
BRPI0515973B1 (pt) | 2018-11-21 |
IL182426A0 (en) | 2007-09-20 |
US7790699B2 (en) | 2010-09-07 |
BRPI0515973B8 (pt) | 2021-07-27 |
RU2393867C2 (ru) | 2010-07-10 |
CA2583373A1 (en) | 2006-04-27 |
BR122018068450B8 (pt) | 2021-07-27 |
US20060159823A1 (en) | 2006-07-20 |
JP5367266B2 (ja) | 2013-12-11 |
US20100303914A1 (en) | 2010-12-02 |
MX2007004261A (es) | 2007-06-18 |
WO2006044342A2 (en) | 2006-04-27 |
EP1799232A4 (en) | 2008-07-16 |
CN101227913B (zh) | 2013-08-14 |
AU2005295927A1 (en) | 2006-04-27 |
AU2005295927B2 (en) | 2012-02-02 |
US20140271576A1 (en) | 2014-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO341594B1 (no) | Biomedisinsk kit for fremstilling av en biokompatibel alginatgel, sammensetning for fremstilling av slike geler, fremgangsmåte for utlevering av en selv-gelerings alginat dispersjon og en implanterbar anordning samt alginatgeler og implanterbare anordninger omfattende slike | |
Pollot et al. | Natural polymeric hydrogel evaluation for skeletal muscle tissue engineering | |
Moulin et al. | Modulated response to cytokines of human wound healing myofibroblasts compared to dermal fibroblasts | |
Wei et al. | A novel thermo-responsive hydrogel based on salecan and poly (N-isopropylacrylamide): Synthesis and characterization | |
Yoon et al. | Heparin‐immobilized biodegradable scaffolds for local and sustained release of angiogenic growth factor | |
AU2018211308A1 (en) | Methods and compositions for in vitro and in vivo chondrogenesis | |
Zhang et al. | Ex vivo cytotoxicity of a new calcium silicate–based canal filling material | |
US5709854A (en) | Tissue formation by injecting a cell-polymeric solution that gels in vivo | |
Tran et al. | Synthesis and characterization of biomimetic citrate‐based biodegradable composites | |
Haagdorens et al. | In vitro cultivation of limbal epithelial stem cells on surface‐modified crosslinked collagen scaffolds | |
MXPA04004534A (es) | Aumento de la funcion de un organo. | |
CN106902392A (zh) | 载肝素/多聚赖氨酸纳米粒子透明质酸水凝胶的制备方法 | |
US20210079170A1 (en) | Preparation method of 4d chitosan-based thermosensitive hydrogel | |
IL276808B2 (en) | Preparations and methods for the treatment of cancer | |
TW201127851A (en) | Surgical grafts for repairing chondral defects | |
Lin et al. | A novel dual-structure, self-healable, polysaccharide based hybrid nanogel for biomedical uses | |
Hu et al. | A mechanically reinforced super bone glue makes a leap in hard tissue strong adhesion and augmented bone regeneration | |
CA2274661A1 (en) | Improved hydrogel for tissue engineering | |
Liu et al. | Incorporation of NGR1 promotes bone regeneration of injectable HA/nHAp hydrogels by anti-inflammation regulation via a MAPK/ERK signaling pathway | |
Catalano et al. | Sol–gel immobilized ovarian follicles: collaboration between two different cell types in hormone production and secretion | |
Fedorovich et al. | The osteoinductive potential of printable, cell‐laden hydrogel‐ceramic composites | |
CN107343968A (zh) | 一种可用于组织工程的植物单宁冷冻水凝胶及其制备方法和应用 | |
Chaterji et al. | Enhanced osteoblast‐like cell adhesion and proliferation using sulfonate‐bearing polymeric scaffolds | |
Tan et al. | The effect of 58S bioactive sol-gel derived foams on the growth of murine lung epithelial cells | |
CN111876384B (zh) | 一种肿瘤组织植入液及其制备方法与用途 |